SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-033340
Filing Date
2024-04-16
Accepted
2024-04-16 14:39:35
Documents
16
Period of Report
2024-04-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204004-8k_inmed.htm   iXBRL 8-K 37675
2 NEWS RELEASE, DATED APRIL 16, 2024 ea020400401ex99-1_inmed.htm EX-99.1 19514
7 GRAPHIC ex99-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-24-033340.txt   272724

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20240416.xsd EX-101.SCH 3021
4 XBRL DEFINITION FILE inm-20240416_def.xml EX-101.DEF 26195
5 XBRL LABEL FILE inm-20240416_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE inm-20240416_pre.xml EX-101.PRE 22364
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0204004-8k_inmed_htm.xml XML 3797
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 24847364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)